- Each component assayed to ≥99% (HPLC); per-lot COA on request
- Certificate of analysis tied to your lot number
- Tracked EU delivery, dispatched the next working day
CJC-1295 (No DAC) + GHRP-6
Mod GRF (1-29) combined with GHRP-6, the original hexapeptide GH secretagogue
In stock1 format availableCAS CJC-1295 (No DAC): 863288-34-0 · GHRP-6: 87616-84-0
€85
This listing is currently unavailable. Contact us and we will tell you when it is back or suggest an equivalent.
Ask about this listing or request its COA- FormCo-lyophilized powder, sealed glass vial
- Mol. weightCJC-1295 (No DAC): 3367.93 g/mol · GHRP-6: 873.01 g/mol
- Research areasPulsatile GH release, orexigenic and feeding-behaviour models, GHS-receptor pharmacology, cardiac tissue models
For laboratory research use only. Sold exclusively for in-vitro laboratory research by qualified professionals. Not for human or veterinary use, and not a medicine, food, cosmetic or dietary supplement. Terms and Conditions
Overview
Key facts
In this blend, CJC-1295 without DAC — the DPP-4-resistant 29-residue GHRH analogue better known as Modified GRF (1-29) — is paired with GHRP-6, the hexapeptide from which the whole growth hormone-releasing peptide class grew.
- CAS number
- CJC-1295 (No DAC): 863288-34-0 · GHRP-6: 87616-84-0
- Molecular formula
- CJC-1295 (No DAC): C152H252N44O42 · GHRP-6: C46H56N12O6
- Molecular weight
- CJC-1295 (No DAC): 3367.93 g/mol · GHRP-6: 873.01 g/mol
- Purity
- ≥99% by HPLC per component; lot-matched COA available
- Form
- Co-lyophilized powder, sealed glass vial
- Storage
- Lyophilized: −20 °C, protected from light and moisture. Reconstituted: 2–8 °C, use within the study window.
- Available size
- 10 mg · (5/5)
For research use only. Not for human consumption.
In this blend, CJC-1295 without DAC — the DPP-4-resistant 29-residue GHRH analogue better known as Modified GRF (1-29) — is paired with GHRP-6, the hexapeptide from which the whole growth hormone-releasing peptide class grew. GHRP-6 was developed in the 1980s from met-enkephalin analogues, long before ghrelin had been found, and work on it led scientists to the receptor now called the growth hormone secretagogue receptor. Ghrelin was identified later as that receptor's natural ligand.
GHRP-6 lacks selectivity — and that is exactly why researchers still use it. Besides releasing growth hormone, it strongly stimulates appetite via central ghrelin receptors and, at higher exposure, measurably raises cortisol and prolactin. Groups investigating feeding behaviour, orexigenic pathways or the wider pharmacology of this receptor often choose it over the cleaner second-generation peptides for that very reason.
What sets this listing apart
CJC-1295 (No DAC) + GHRP-6 combines CJC-1295 and GHRP-6 in one listing (10 mg). Components that are also sold on their own are linked below, each with its own specification and COA.
Same compound, other listings
Specifications
Identity
- CAS number
- CJC-1295 (No DAC): 863288-34-0 · GHRP-6: 87616-84-0
- Molecular formula
- CJC-1295 (No DAC): C152H252N44O42 · GHRP-6: C46H56N12O6
- Molecular weight
- CJC-1295 (No DAC): 3367.93 g/mol · GHRP-6: 873.01 g/mol
- Peptide class
- GHRH analogue combined with a first-generation growth hormone-releasing hexapeptide
Supply & purity
- Form
- Co-lyophilized powder, sealed glass vial
- Purity
- ≥99% by HPLC per component; lot-matched COA available
- Available sizes
- 10 mg (5 mg/5 mg)
- Solubility
- Bacteriostatic water
Additional detail
- Blend ratio
- 1:1 CJC-1295 (No DAC) to GHRP-6
- CJC-1295 sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
- GHRP-6 sequence
- His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
- Research areas
- Pulsatile GH release, orexigenic and feeding-behaviour models, GHS-receptor pharmacology, cardiac tissue models
- Storage
- Lyophilized: −20 °C, protected from light and moisture. Reconstituted: 2–8 °C, use within the study window.
Questions about CJC-1295 (No DAC) + GHRP-6
How does GHRP-6 compare with GHRP-2 and ipamorelin?
All three activate the growth hormone secretagogue receptor, but with different selectivity. GHRP-6, the first of them, is the least selective, driving strong appetite effects plus detectable cortisol and prolactin changes. GHRP-2 is more potent with a weaker appetite response, and ipamorelin is the most selective.
What is CJC-1295 (No DAC)?
A 29-amino-acid GHRH analogue carrying four substitutions that protect it from DPP-4, widely sold as Modified GRF (1-29). Lacking the Drug Affinity Complex, it does not attach to albumin, so its action is short and pulse-like instead of prolonged.
Are the two components tested individually?
Yes. An independent laboratory confirms each peptide's purity by HPLC and identity by mass spectrometry before they are co-lyophilised. The certificate matched to your vial's lot number can be requested at any time.
What are the storage requirements?
Store the unopened lyophilised vial at −20 °C, away from light and humidity, where it keeps for a long time. After reconstitution, refrigerate at 2–8 °C and use it within your study period, avoiding repeated freeze–thaw cycles and long spells at room temperature.
